Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
1998-5-29
pubmed:abstractText
We analyzed protein fractions extracted from the spinal cord of the motor neuron degeneration (Mnd) mouse, a mutant that exhibits progressive degeneration of lower spinal motor neurons, by one- and two-dimensional polyacrylamide gel electrophoresis (PAGE) after solubilization of the tissue with medium containing sodium dodecyl sulfate (SDS)-urea during growth of the animal, in comparison with those of age-matched controls (C57BL/6). Several protein spots were detected around a region of pI 5.6-6.0 and molecular mass of 35-50 kDa in Mnd spinal cord tissue on the two-dimensional PAGE separation profile with Coomassie brilliant blue staining, while only a few spots around the same region were found in the control spinal cord. These spots were all immunoreactive with an antibody against glial fibrillary acidic protein (GFAP), a cytoskeleton filamentous protein specific to astroglial cells. The protein spot with molecular mass of 50 kDa showed immunoreactivity with anti-GFAP antibody, had a blocked amino-terminus, and is assumed to be intact GFAP. Several protein spots with slightly smaller molecular masses of 35 to 48 kDa lacked the head domain of the GFAP molecule as a result of cleavage at the 29th and 56th residues from the amino terminus. In Mnd spinal cord tissue, the densities of the immunoreactive GFAP bands with smaller molecular masses increased with development, and became dominant at the time of the appearance of behavioral paralytic gait around 6 to 7 months of age. These results suggest that the increased GFAPs devoid of head domains are related to the degenerative loss of motor neurons in the Mnd spinal cord. Histopathological and GFAP immunohistochemical examination of Mnd spinal cord preparation demonstrated progressive degenerative loss of motor neurons, and considerable increases in number of GFAP-stained astrocytes in the ventral horn at 7 to 9 months of age. These processes of degenerative loss of motor neurons and proliferation of reactive astrocytes with increased levels of fragmented GFAP in the Mnd spinal cord during development seem to be characteristic and preceded the deterioration of motor activities in this animal model of amyotrophic lateral sclerosis.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Feb
pubmed:issn
0006-8993
pubmed:author
pubmed:copyrightInfo
Copyright 1998 Elsevier Science B.V.
pubmed:issnType
Print
pubmed:day
23
pubmed:volume
785
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
31-40
pubmed:dateRevised
2006-11-15
pubmed:meshHeading
pubmed-meshheading:9526038-Amino Acid Sequence, pubmed-meshheading:9526038-Amyotrophic Lateral Sclerosis, pubmed-meshheading:9526038-Animals, pubmed-meshheading:9526038-Disease Models, Animal, pubmed-meshheading:9526038-Electrophoresis, Gel, Two-Dimensional, pubmed-meshheading:9526038-Electrophoresis, Polyacrylamide Gel, pubmed-meshheading:9526038-Glial Fibrillary Acidic Protein, pubmed-meshheading:9526038-Homozygote, pubmed-meshheading:9526038-Humans, pubmed-meshheading:9526038-Immunohistochemistry, pubmed-meshheading:9526038-Mice, pubmed-meshheading:9526038-Mice, Inbred C57BL, pubmed-meshheading:9526038-Mice, Neurologic Mutants, pubmed-meshheading:9526038-Molecular Sequence Data, pubmed-meshheading:9526038-Motor Neuron Disease, pubmed-meshheading:9526038-Motor Neurons, pubmed-meshheading:9526038-Nerve Degeneration, pubmed-meshheading:9526038-Peptide Fragments, pubmed-meshheading:9526038-Reference Values, pubmed-meshheading:9526038-Spinal Cord
pubmed:year
1998
pubmed:articleTitle
Increase of glial fibrillary acidic protein fragments in the spinal cord of motor neuron degeneration mutant mouse.
pubmed:affiliation
Department of Physiology, School of Medicine, Toyoake, Aichi 470-11, Japan. myamauti@fujita-hu.ac.jp
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't